Inventor · disambiguated record
Michael Louis Miller
Also filed as: MILLER MICHAEL · MILLER MICHAEL L · MILLER MICHAEL LOUIS
56 granted patents·15 pending applications·1,055 citations·filing 2001–2024
99Inventor score
Top patents by PatentIndex Score
71 records- 0199US8809320B2Benzodiazepine derivativesLI WEI·Filed 2013·Granted Aug 19, 2014·56 cites·22 claims
- 0299US8802667B2Benzodiazepine derivativesLI WEI·Filed 2013·Granted Aug 12, 2014·55 cites·20 claims
- 0399US6716821B2Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the sameIMMUNOGEN INC·Filed 2001·Granted Apr 6, 2004·359 cites·92 claims
- 0499US6596757B1Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic useIMMUNOGEN INC·Filed 2002·Granted Jul 22, 2003·165 cites·48 claims
- 0598US9434748B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Sep 6, 2016·15 cites·25 claims
- 0698US8889669B2Cytotoxic benzodiazepine derivativesLI WEI·Filed 2013·Granted Nov 18, 2014·32 cites·40 claims
- 0798US8765740B2Cytotoxic benzodiazepine derivativesLI WEI·Filed 2012·Granted Jul 1, 2014·59 cites·56 claims
- 0897US9169272B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2014·Granted Oct 27, 2015·19 cites·16 claims
- 0997US8426402B2Benzodiazepine derivativesLI WEI·Filed 2010·Granted Apr 23, 2013·69 cites·23 claims
- 1096US10208127B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Feb 19, 2019·6 cites·6 claims
- 1196US10179818B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Jan 15, 2019·6 cites·24 claims
- 1296US9868791B2Methods of preparation of conjugatesIMMUNOGEN INC·Filed 2016·Granted Jan 16, 2018·8 cites·12 claims
- 1396US9840564B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Dec 12, 2017·7 cites·3 claims
- 1495US9353127B2Methods of preparation of conjugatesFISHKIN NATHAN·Filed 2012·Granted May 31, 2016·28 cites·69 claims
- 1594US9265841B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2014·Granted Feb 23, 2016·7 cites·12 claims
- 1693US10570212B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Feb 25, 2020·3 cites·14 claims
- 1793US9550787B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Jan 24, 2017·4 cites·9 claims
- 1893US9381256B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Jul 5, 2016·12 cites·20 claims
- 1993US7414073B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2004·Granted Aug 19, 2008·42 cites·57 claims
- 2091US10947315B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Mar 16, 2021·2 cites·8 claims
- 2191US10787463B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Sep 29, 2020·1 cites·25 claims
- 2291US7667054B2Cytotoxic agents comprising new taxanesAVENTIS PHARMA SA·Filed 2005·Granted Feb 23, 2010·20 cites·48 claims
- 2391US7598290B2Cytotoxic agents comprising new C-2 modified taxanesIMMUNOGEN INC·Filed 2007·Granted Oct 6, 2009·20 cites·45 claims
- 2490US10081640B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Sep 25, 2018·5 cites·18 claims
- 2589US11390633B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Jul 19, 2022·1 cites·9 claims
- 2689US10385071B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Aug 20, 2019·3 cites·19 claims
- 2788US10844078B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Nov 24, 2020·2 cites·20 claims
- 2888US10370389B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Aug 6, 2019·3 cites·22 claims
- 2988US9669102B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Jun 6, 2017·5 cites·28 claims
- 3088US2023257400A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 3187US9873708B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Jan 23, 2018·3 cites·22 claims
- 3287US9617270B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Apr 11, 2017·3 cites·13 claims
- 3386US10442809B2Methods for preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-6-onesIMMUNOGEN INC·Filed 2018·Granted Oct 15, 2019·2 cites·15 claims
- 3485US10364294B2Methods of preparation of conjugatesIMMUNOGEN INC·Filed 2017·Granted Jul 30, 2019·2 cites·3 claims
- 3585US10238751B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Mar 26, 2019·3 cites·20 claims
- 3685US9890179B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Feb 13, 2018·2 cites·19 claims
- 3783US10898579B2Conjugates of cysteine engineered antibodiesIMMUNOGEN INC·Filed 2016·Granted Jan 26, 2021·3 cites·11 claims
- 3882US10968228B2Methods of preparing substituted 12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indolesIMMUNOGEN INC·Filed 2019·Granted Apr 6, 2021·1 cites·20 claims
- 3982US7495114B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2004·Granted Feb 24, 2009·10 cites·38 claims
- 4082US2024067652A1Method of preparing indolinobenzodiazepine derivativesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 4181USRE49918ECytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2021·Granted Apr 16, 2024·0 cites·14 claims
- 4281US2023233697A1Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 4380US11981687B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Granted May 14, 2024·0 cites·23 claims
- 4479US11505617B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2021·Granted Nov 22, 2022·0 cites·4 claims
- 4579US11420982B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 4679US10899775B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Jan 26, 2021·0 cites·22 claims
- 4779US2021171547A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Application pending·0 cites
- 4878US10722588B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Jul 28, 2020·1 cites·17 claims
- 4976US9974867B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted May 22, 2018·1 cites·20 claims
- 5076US7390898B2Cytotoxic agents containing novel potent taxanes and their therapeutic useIMMUNOGEN INC·Filed 2003·Granted Jun 24, 2008·9 cites·131 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Louis Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →